Nicholas Jason Singer insider trades: Eterna Therapeutics (ERNA) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Nicholas reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 2, 2022 | ERNA | ↑ Buy | 212,464 | $3.28 | $697K | By Pacific Premier Trust, Custodian, FBO | Dec 6, 2022 (4d) |
| Dec 2, 2022 | ERNA | ↑ Buy | 70,822 | $3.28 | $232K | By Purchase Capital LLC | Dec 6, 2022 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ERNA insiders
Open-market trades in the last 12 months
About Nicholas Jason Singer's insider trades
Nicholas Jason Singer is an insider at Eterna Therapeutics (ERNA). Since Dec 2, 2022, Nicholas has reported 2 open-market purchases worth $929K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (3 filings), grants and awards (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ERNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.